To evaluate the best timing of the concomitant chemoradiotherapy among patients with NSCLC
stage III not resectable treated by concomitant chemo-radiotherapy, either preceded by a
induction chemotherapy, or followed by a consolidation chemotherapy.
Phase:
Phase 2
Details
Lead Sponsor:
Intergroupe Francophone de Cancerologie Thoracique
Collaborators:
Bristol-Myers Squibb Ligue contre le cancer, France Pierre Fabre Laboratories